The Drum · Weekly AI news, freeSubscribe →
Timeline
The integration of artificial intelligence (AI) in healthcare has transformed diagnostic and therapeutic processes, enhancing patient care while introducing new challenges regarding data privacy and regulatory compliance. AI tools have been developed to analyze medical images, predict disease progression, personalize treatments, and manage electronic health records. However, the rapid advancement of these technologies has outpaced existing regulatory frameworks, leading to debates over how best to ensure safety and efficacy without stifling innovation.
The Story
The story of AI in healthcare regulation begins with early attempts to use machine learning for disease diagnosis. As AI capabilities have grown, so too has the complexity of regulatory oversight. Key milestones include the introduction of specific guidelines by global health agencies and ongoing debates about how to incorporate AI into existing medical frameworks without compromising patient safety or privacy. Despite these challenges, there is a growing consensus that adaptive regulation will be essential for unlocking the full potential of AI in healthcare.
1956
AI Concept Emerges
The term 'artificial intelligence' was coined at Dartmouth Conference, initiating foundational research that would later influence healthcare applications.
1972-04
First Medical Expert System
MYCIN, an early AI program designed to diagnose bacterial infections and recommend antibiotics based on patient data, marks the beginning of AI's role in healthcare.
1983-04
First Clinical Trial Using AI
MYCIN undergoes clinical trials, showcasing the potential of AI to support medical decision-making and improve patient outcomes.
1986-04
AI in Radiology
Early work on AI-driven image analysis starts with research focusing on detecting abnormalities in mammograms.
1995-04
First FDA Approval for Medical Device Software
The U.S. Food and Drug Administration (FDA) approves the first software-based medical device, setting a precedent for regulating AI tools.
2013-04
Google's DeepMind Founded
DeepMind Health is launched to explore applications of machine learning in healthcare, focusing on improving patient care through data analysis.
2015-04
AI for Cancer Detection
IBM Watson Health collaborates with medical institutions to develop AI systems capable of diagnosing cancer from patient records and imaging data.
2016-04
AI in Drug Discovery
Companies start using machine learning to accelerate drug discovery, aiming to reduce the time and cost of bringing new treatments to market.
2018-04
FDA Guidance on AI/ML Devices
The FDA issues guidance for the regulation of medical devices that use artificial intelligence and machine learning algorithms, aiming to provide clarity for developers.
2019-04
European Commission AI Ethics Guidelines
The European Union's High-Level Expert Group on Artificial Intelligence publishes ethics guidelines for trustworthy AI, including considerations for healthcare applications.
2019-04
AI in Mental Health Diagnosis
Startups develop AI tools to diagnose and treat mental health disorders, leveraging data from patient interactions and behavioral patterns.
2019-04
Google's DeepMind Partnership
DeepMind partners with the NHS to create Streams, an app designed to help clinicians detect and treat acute kidney injury earlier.
2019-04
FDA Clears AI for Ophthalmology
The FDA clears IDx-DR, the first autonomous AI diagnostic tool to detect diabetic retinopathy without requiring a clinician's interpretation.
2019-04
AI in Surgical Robotics
Robotic surgery systems incorporate AI to enhance precision and reduce human error during complex procedures.
2020-04
FDA's Digital Health Program Expansion
The FDA announces the expansion of its digital health program to accelerate innovation in AI and mobile medical applications.
2021-04
AI for Pandemic Response
AI technologies are rapidly deployed to track the spread of COVID-19, predict hospital needs, and develop new treatments.
2021-04
Global AI Ethics Frameworks
Governments and international bodies introduce comprehensive frameworks for ethical use of AI in healthcare, addressing issues like data privacy and algorithmic bias.
2021-04
AI Mental Health Therapy
Chatbots and virtual therapists powered by AI begin to offer mental health support, expanding access to treatment in underserved areas.
2021-04
AI for Rare Disease Diagnosis
Specialized AI tools are developed to aid in diagnosing rare diseases based on genetic data and clinical symptoms.
2021-04
AI Drug Repurposing Platforms
Emerging platforms use AI to identify new uses for existing drugs, accelerating clinical trials and potentially reducing development costs.
2021-04
FDA's Digital Health Innovation Action Plan
The FDA outlines a comprehensive action plan to promote innovation in digital health technologies, including AI.
2021-04
AI for Personalized Medicine
Advancements in genomic sequencing enable the use of AI to develop highly personalized treatment plans based on individual genetic profiles.
2021-04
AI for Rehabilitation and Therapy
Robotic devices controlled by AI are introduced to assist in physical rehabilitation, providing precise movements and real-time feedback.
© 2026 Cedar & Bloom. All rights reserved.
